This compound is a difluorinated tetrahydrofuran derivative featuring two benzoate ester groups and a methylsulfonyloxy leaving group, configured with defined stereochemistry. It serves as a pharmaceutical intermediate for the synthesis of nucleoside analogs in research and development settings.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 134877-42-2
1-O-Acetyl-3,5-bis (4-Chlorobenzoyl)-2-Deoxy-D-ribose
Pharmaceutical intermediate for nucleoside analogs
Uridine, 2'-deoxy-2'-fluoro-, 3',5'-diacetate
Pharmaceutical intermediate for nucleoside analogs
(2R,3R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
Pharmaceutical intermediate for nucleoside analogs
6-(Benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-9H-purin-2-amine
Pharmaceutical intermediate for nucleoside analogs
1-(4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)phenyl)ethanone
Intermediate for bexarotene impurity synthesis
2-[2-(2-aminoethoxy)ethoxy]acetic acid;hydrochloride
Pharmaceutical intermediate for pegylation
(1S,5R)-8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Ol
pharmaceutical intermediate
Dibenzyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate
protected proline derivative for peptide synthesis
[(2R,3R,5R)-3-benzoyloxy-4,4-difluoro-5-methylsulfonyloxyoxolan-2-yl]methyl benzoate
LIAQHZDWFACWFK-GPMSIDNRSA-N
CS(=O)(=O)O[C@@H]1C([C@@H]([C@H](O1)COC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)(F)F